Filing Flows › Comparisons › MDGL vs PAHC
Madrigal Pharmaceuticals vs Phibro Animal Health: MDGL and PAHC compared
Madrigal Pharmaceuticals is the larger company: $431M of revenue in its latest quarter (Q3 2026) against $387M for Phibro Animal Health (Q1 FY27). Madrigal Pharmaceuticals is growing faster (+50% against +6% a year earlier). Madrigal Pharmaceuticals is more profitable, with an operating margin of 13.0% against 12.8%.
Where the money goes: MDGL and PAHC
Madrigal Pharmaceuticals (MDGL) · Q3 2026
Madrigal Pharmaceuticals, Q3 2026: revenue $431M (+50% year over year), operating margin 13.0%, net earnings $55.4M, operating cash flow $121M. The chart follows the revenue to costs, profit and cash.
Phibro Animal Health (PAHC) · Q1 FY27
Phibro Animal Health, Q1 FY27: revenue $387M (+6% year over year), operating margin 12.8%, net earnings $29.5M, operating cash flow $26.1M. The chart follows the revenue to costs, profit and cash.
| Madrigal Pharmaceuticals (MDGL) | Phibro Animal Health (PAHC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $431M | $387M |
| Revenue growth, Y/Y | +50% | +6% |
| Gross margin | — | 33.2% |
| Operating margin | 13.0% | 12.8% |
| Net earnings | $55.4M | $29.5M |
| Net margin | 12.9% | 7.6% |
| Operating cash flow | $121M | $26.1M |
| Free cash flow | $117M | $7.3M |
| Market value | $12.1B | $1.3B |
| P/E | — | 13.2× |
| Analysts’ mean target | $688.94 | $47.00 |
Where the revenue comes from
Phibro Animal Health
- Animal Health: $293M (76%)
- Mineral Nutrition: $73.6M (19%)
- Performance Products: $20.2M (5%)
Questions
Which is bigger, Madrigal Pharmaceuticals or Phibro Animal Health?
Madrigal Pharmaceuticals is the larger company: $431M of revenue in its latest quarter (Q3 2026) against $387M for Phibro Animal Health (Q1 FY27).
Is Madrigal Pharmaceuticals or Phibro Animal Health growing faster?
Madrigal Pharmaceuticals is growing faster (+50% against +6% a year earlier).
Which is more profitable, Madrigal Pharmaceuticals or Phibro Animal Health?
Madrigal Pharmaceuticals is more profitable, with an operating margin of 13.0% against 12.8%.
More: Madrigal Pharmaceuticals earnings · how Madrigal Pharmaceuticals makes money · Phibro Animal Health earnings · how Phibro Animal Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.